Health software company Alcidion Group (ASX: ALC) has secured yet another contract in the UK after Dartford and Gravesham NHS Trust elected it preferred technology provider to deploy an electronic prescription medications administration system.
After a competitive tender process, Alcidion was selected to deploy Better by Marand’s OPENeP electronic medical management system for the trust.
“We are delighted to extend our existing relationship with Dartford and Gravesham NHS Trust,” Alcidion managing director Kate Quirke said.
“This selection of Alcidion demonstrates the breadth of our capabilities and our value as the Trust’s strategic partner to support its goal of being paperless at the point of care by 2020.”
Ms Quirke added the tender was the first major one Alcidion had won to roll-out the OPENeP platform.
“This demonstrates the power of our expanded portfolio of complementary products and solutions that sit alongside Miya and Patientrack, enabling us to offer a truly best-of-breed integrated solution that covers a wide range of clinical needs including next generation medications management.”
Prior to the roll-out, the deal is subject to final contract approvals which are expected later this year.
Todays news follows Alcidion reporting last month the Western Sussex Hospitals NHS Trust had inked a five-year contract to continue using and receiving support for Patientrack.
According to Alcidion, Western Sussex Hospitals NHS Trust initially implemented Patientrack in 2012.
Under the five-year renewal, the mobile and digital bedside system will continue to be used in 68 wards across three hospitals through to 2024, with the contract anticipated to be worth $970,000 to Alcidion.
Alcidion claims Patientrack helps hospitals improve patient safety, quality of care and efficiency by planning and performing patient observations and assessments and providing clinical documentation at the bedside in real-time.
Meanwhile, back in Australia, Alcidion is working on building and integrating two key components for a proposed national Child Digital Health Record, which will be trialled in two NSW health districts.
The $700,000 in contract value is expected to be recognised in the current financial year through the length of the project.
Shares in Alcidion were up 6.25% to $0.17 in early morning trade.